Adolescent alcohol and other drug (AOD) use is a significant public health problem which contributes to high levels of mortality, morbidity and healthcare costs in young people, and identification and early intervention for these problems is critical to improving outcomes. Screening, Brief Intervention and Referral to Treatment (SBIRT) in pediatric primary care is an evidence-based strategy for addressing these problems, but has not been widely and systematically implemented, for a variety of reasons, including lack of training and staffing resources to support its implementation. This pragmatic, Type 1 Hybrid Comparative Effectiveness Implementation study will examine whether a centralized, virtually-delivered modality of SBIRT, rapidly accessible by multiple pediatric primary care clinics, can be cost-effectively implemented to improve early identification and treatment for AOD use and comorbid mental health problems among adolescents identified as being at high or severe risk of AOD use disorder during adolescent Well Visits.
Age range
12 Years – 17 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Referrals to behavioral health clinicians for SBIRT
Timeframe: During the 2 year intervention period
Brief Interventions
Timeframe: During the 2-year intervention period
Referrals
Timeframe: During the 2-year intervention period
Specialty Treatment Initiation
Timeframe: Within 2 months of the index screening visit.
Specialty Treatment Engagement
Timeframe: Within 34 days of the initial specialty care initiation encounter.
AOD and Mental Health Diagnoses
Timeframe: within 1 year and 2 years of the index screening visit
Alcohol and other drug use
Timeframe: 1- and 2-year follow-up visits.
Depressive symptoms
Timeframe: 1- and 2-year follow-up visits.
Suicidality
Timeframe: 1- and 2-year follow-up visits.
Health Services Utilization
Timeframe: Within 1 year and 2 years of the index screening visit.